ACKGROUND: In vascular reconstructive surgery, myointimal hyperplasia contributes to the adverse outcome of synthetic grafts. This phenomenon is because of unregulated extracellular matrix degradation and remodeling, and excessive smooth muscle cell proliferation and migration. Matrix metallopreoteinase 2 (MMP-2) is known as an important contributor to these events. The aims of our study was to investigate the effects of selective MMP-2 inhibitor (TIMP-2) in endothelialization rate, SMC proliferation, and myointimal hyperplasia in experimental ePTFE arterial grafts. METHODS: In 20 male Lewis rats, a 1-cm long ePTFE graft has been inserted at the level of the abdominal aorta. Animals were randomized in two groups (10 animals each): group A received six subcutaneous inoculations of TIMP-2 (2.5 microg) after surgery, group B received only the vehicle of TIMP-2. RESULTS: Neointimal thickness, as well as SMC density, were augmented in group B, whereas endothelial cells density was augmented in group A, and these findings were statistically significant. In group A SMC were better organized, just like SMC of thoracic aorta. In group B SMC were no organized. Furthermore, anti-TIMP-2 and anti-MMP-2 coloration revealed higher levels of TIMP-2 and lower levels of MMP-2 in group A versus group-B. CONCLUSIONS: Use of TIMP-2 affects the neointimal formation of experimental e-PTFE arterial grafts, leading to a better-organized neointima, with improved endothelialization.

TIMP-2 modulates neointimal formation in experimental ePTFE arterial grafts / Cavallaro, Giuseppe; Cucina, Alessandra; Randone, Bruto; Polistena, Andrea; Mosiello, Giovanni; Coluccia, Pierpaolo; DE TOMA, Giorgio; Cavallaro, Antonino.. - In: JOURNAL OF SURGICAL RESEARCH. - ISSN 0022-4804. - 137:1(2007), pp. 122-129. [10.1016/j.jss.2006.07.038]

TIMP-2 modulates neointimal formation in experimental ePTFE arterial grafts

Cavallaro Giuseppe;Cucina Alessandra;Randone Bruto;Polistena Andrea;Mosiello Giovanni;Coluccia Pierpaolo;De Toma Giorgio;Cavallaro Antonino.
2007

Abstract

ACKGROUND: In vascular reconstructive surgery, myointimal hyperplasia contributes to the adverse outcome of synthetic grafts. This phenomenon is because of unregulated extracellular matrix degradation and remodeling, and excessive smooth muscle cell proliferation and migration. Matrix metallopreoteinase 2 (MMP-2) is known as an important contributor to these events. The aims of our study was to investigate the effects of selective MMP-2 inhibitor (TIMP-2) in endothelialization rate, SMC proliferation, and myointimal hyperplasia in experimental ePTFE arterial grafts. METHODS: In 20 male Lewis rats, a 1-cm long ePTFE graft has been inserted at the level of the abdominal aorta. Animals were randomized in two groups (10 animals each): group A received six subcutaneous inoculations of TIMP-2 (2.5 microg) after surgery, group B received only the vehicle of TIMP-2. RESULTS: Neointimal thickness, as well as SMC density, were augmented in group B, whereas endothelial cells density was augmented in group A, and these findings were statistically significant. In group A SMC were better organized, just like SMC of thoracic aorta. In group B SMC were no organized. Furthermore, anti-TIMP-2 and anti-MMP-2 coloration revealed higher levels of TIMP-2 and lower levels of MMP-2 in group A versus group-B. CONCLUSIONS: Use of TIMP-2 affects the neointimal formation of experimental e-PTFE arterial grafts, leading to a better-organized neointima, with improved endothelialization.
2007
eptfe grafts; extracellular matrix; timp-2
01 Pubblicazione su rivista::01a Articolo in rivista
TIMP-2 modulates neointimal formation in experimental ePTFE arterial grafts / Cavallaro, Giuseppe; Cucina, Alessandra; Randone, Bruto; Polistena, Andrea; Mosiello, Giovanni; Coluccia, Pierpaolo; DE TOMA, Giorgio; Cavallaro, Antonino.. - In: JOURNAL OF SURGICAL RESEARCH. - ISSN 0022-4804. - 137:1(2007), pp. 122-129. [10.1016/j.jss.2006.07.038]
File allegati a questo prodotto
File Dimensione Formato  
Cavallaro_Timp-2_2007.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.75 MB
Formato Adobe PDF
2.75 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1146553
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact